13 research outputs found
Analytical methodologies based on LC–MS/MS for monitoring selected emerging compounds in liquid and solid phases of the sewage sludge
In this work, two analytical methodologies based on liquid chromatography coupled to tandem mass
spectrometry (LC–MS/MS) were developed for quantification of emerging pollutants identified in sewage sludge
after a previous wide-scope screening. The target list included 13 emerging contaminants (EC): thiabendazole,
acesulfame, fenofibric acid, valsartan, irbesartan, salicylic acid, diclofenac, carbamazepine, 4-aminoantipyrine (4-
AA), 4-acetyl aminoantipyrine (4-AAA), 4-formyl aminoantipyrine (4-FAA), venlafaxine and benzoylecgonine. The
aqueous and solid phases of the sewage sludge were analyzed making use of Solid-Phase Extraction (SPE) and
UltraSonic Extraction (USE) for sample treatment, respectively. The methods were validated at three
concentration levels: 0.2, 2 and 20mg L 1 for the aqueous phase, and 50, 500 and 2000mg kg 1 for the solid
phase of the sludge. In general, the method was satisfactorily validated, showing good recoveries (70–120%) and
precision (RSD < 20%). Regarding the limit of quantification (LOQ), it was below 0.1mg L 1 in the aqueous phase
and below 50mg kg 1 in the solid phase for the majority of the analytes. The method applicability was tested by analysis of samples from a wider study on degradation of emerging pollutants in sewage sludge under anaerobic
digestion.
The key benefits of these methodologies are:
SPE and USE are appropriate sample procedures to extract selected emerging contaminants from the aqueous
phase of the sewage sludge and the solid residue.
LC–MS/MS is highly suitable for determining emerging contaminants in both sludge phases.
Up to our knowledge, the main metabolites of dipyrone had not been studied before in sewage sludge.
ãFinancial support of Generalitat Valenciana (Prometeo II/2014/023,ISIC/2014/016
Behaviour of emerging contaminants in sewage sludge after anaerobic digestion
Nowadays, there is an increasing concern over the presence of contaminants in the aquatic environment, where they can be introduced from wastewater after their incomplete removal in the treatment plants. In this work, degradation of selected emerging pollutants in the aqueous and solid phases of sewage sludge has been investigated after anaerobic digestion using two different digesters: mesophilic and thermophilic. Initially, sludge samples were screened by ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UHPLC-QTOF MS) for identification of emerging contaminants in the samples. In a second step, a target quantitative method based on LC coupled to tandem MS was applied for selected pollutants identified in the previous screening. The behaviour of the compounds under anaerobic conditions was studied estimating the degradation efficiency and distribution of compounds between both sludge phases. Irbesartan and benzoylecgonine seemed to be notably degraded in both phases of the sludge. Venlafaxine showed a significant concentration decrease in the aqueous phase in parallel to an increase in the solid phase. The majority of the compounds showed an increase of their concentrations in both phases after the digestion. Concentrations in the solid phase were commonly higher than in the aqueous for most contaminants, indicating that they were preferentially adsorbed onto the solid particles.The authors are very grateful to the Ecophysiology and Biotechnology group (University Jaume I) and to The Institute of Aquaculture “Torre de la Sal” (IATS) (Consejo Superior de Investigaciones Científicas, CSIC) for using their lyophilizer systems. The financial support of Generalitat Valenciana (Prometeo II/2014/023, ISIC/2014/016) is also acknowledged
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3–5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant’s success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes. © 2021, The Author(s), under exclusive licence to Springer Nature Limited
Changes of the mucosal N3 and N6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence
Despite data favouring a role of dietary fat in colonic carcinogenesis, no study has focused on tissue n3 and n6 fatty acid (FA) status in human colon adenoma-carcinoma sequence. Thus, FA profile was measured in plasma phospholipids of patients with colorectal cancer (n = 22), sporadic adenoma (n = 27), and normal colon (n = 12) (control group). Additionally, mucosal FAs were assessed in both diseased and normal mucosa of cancer (n = 15) and adenoma (n = 21) patients, and from normal mucosa of controls (n = 8). There were no differences in FA profile of both plasma phospholipids and normal mucosa, between adenoma and control patients. There were considerable differences, however, in FAs between diseased and paired normal mucosa of adenoma patients, with increases of linoleic (p = 0.02), dihomogammalinolenic (p = 0.014), and eicosapentaenoic (p = 0.012) acids, and decreases of alpha linolenic (p = 0.001) and arachidonic (p = 0.02) acids in diseased mucosa. A stepwise reduction of eicosapentaenoic acid concentrations in diseased mucosa from benign adenoma to the most advanced colon cancer was seen (p = 0.009). Cancer patients showed lower alpha linolenate (p = 0.002) and higher dihomogammalinolenate (p = 0.003) in diseased than in paired normal mucosa. In conclusion changes in tissue n3 and n6 FA status might participate in the early phases of the human colorectal carcinogenesis